That is very important, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (tech predictions). However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was an advancement nearly no one observed. But it's going to have profound implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment chances in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown 2020 predictions). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably prior to going greater - jeff bezos. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. However that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. exponential growth. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous excellent personal companies on the verge of hitting the general public markets And I've been dealing with a new way for you to invest even before these business go public.
This opportunity has actually been developing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your spot for complimentary.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our normal beat (brownstone research). And when it pertains to tech investing, we leave it to the specialists. The good news is, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we know (jeff brown 1 biotech). In fact, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and producing unbelievable chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. united arab emirates. But despite what many readers might believe, this is a trend that's just getting going. Even though the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 1 biotech). Losing two months of production and sales actually impacts the number of 5G gadgets are sold in the calendar year. When you consider all of that, offering 250 million systems is amazing. More significantly, the hold-ups brought on by the pandemic produced a lots of pent-up demand. Which demand is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - legacy report prediction. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I've described its three various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services begin to be provided (exponential growth). That's when we start to see applications operating on 5G networks. Believe of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: Many people do not really care about the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open a suite of extraordinary applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be massive. Stepping far from 5G, the next important technology I anticipate in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For years, CRISPR was mainly a niche technology that wasn't well understood. And throughout that time, there were truly just 3 business operating in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole industry is effectively a greenfield chance.
There's space for numerous business to exist in this space. united arab emirates. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can properly predict the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is essential because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug therapies produced using this technology. This was one of those advancements that practically no one noticed. However it's going to have extensive ramifications for treating disease. And, obviously, there will be lots of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back possibly significantly before going greater. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin - white house. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown biotech stocks. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, however we might not separately verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent viewpoint on the market. He's always on the hunt for brand-new chances, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully anticipated a few of the biggest financial occasions of the past 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, but Jeff Brown's precise predictions have earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research study offers several research services with a wide variety of expertises - jeff brown latest prediction.
The business is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown predictions for 2021. On its website, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the finest investment research has actually not been readily available to private financiers. It has been normally reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown prediction for 2021. The objective of Brownstone Research study is to make that kind of proprietary research readily available to any financiers aiming to get an edge in the marketplaces. The goal is simple to deliver distinct and lucrative financial investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. genetic sequencing companies jeff brown. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. brownstone research. might be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge innovations: expert system and electric cars and trucks. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the automobile industry's Holy Grail. As you know, electric cars and self-driving car stocks have actually been substantial this year, however the Wall Street maker has actually been big on buzz without much concrete outcome. Despite an extreme increase in competitors over the past few years, Brown still believes Musk has the very best possibility of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transportation. Essentially, this innovation would allow you to rent out your car as an autonomous, self-driving taxi when you're not using it. You simply leave the car and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the earnings. It sounds ridiculous, however it could be closed than you believe.